.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

UBS
Fish and Richardson
Argus Health
Cipla
Medtronic
Dow
Federal Trade Commission
AstraZeneca
Moodys
Deloitte

Generated: September 20, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 090055

« Back to Dashboard
NDA 090055 describes MYCOPHENOLATE MOFETIL, which is a drug marketed by Alkem Labs Ltd, Vintage Pharms Llc, West-ward Pharms Int, Dr Reddys Labs Ltd, Accord Hlthcare, Apotex Corp, Mylan, Zydus Pharms Usa Inc, Sandoz, Strides Pharma, Teva Pharms, Jubilant Cadista, Apotex, Akorn Inc, Mylan Labs Ltd, and Par Sterile Products, and is included in twenty-nine NDAs. It is available from sixteen suppliers. Additional details are available on the MYCOPHENOLATE MOFETIL profile page.

The generic ingredient in MYCOPHENOLATE MOFETIL is mycophenolate mofetil hydrochloride. There are thirty-six drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the mycophenolate mofetil hydrochloride profile page.

Summary for NDA: 090055

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:0
Formulation / Manufacturing:see details

Pharmacology for NDA: 090055

Suppliers and Packaging for NDA: 090055

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
MYCOPHENOLATE MOFETIL
mycophenolate mofetil
CAPSULE;ORAL 090055 ANDA Greenstone LLC 59762-0703 59762-0703-1 100 CAPSULE in 1 BOTTLE, PLASTIC (59762-0703-1)
MYCOPHENOLATE MOFETIL
mycophenolate mofetil
CAPSULE;ORAL 090055 ANDA Greenstone LLC 59762-0703 59762-0703-2 120 CAPSULE in 1 BOTTLE, PLASTIC (59762-0703-2)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrength250MG
Approval Date:Jun 10, 2010TE:ABRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Cerilliant
Federal Trade Commission
Healthtrust
Argus Health
Queensland Health
Merck
Medtronic
Harvard Business School
QuintilesIMS
US Department of Justice

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot